RecruitingNot ApplicableNCT06129760

Glioblastoma Remote Monitoring and Care - Research Protocol


Sponsor

Case Comprehensive Cancer Center

Enrollment

25 participants

Start Date

Apr 30, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this research is to learn more about how what the Apple watch measures, in terms of walking data, heart rate, breathing rate, and sleep habits, relates to how participants feel. During the course of the treatment, the symptoms participants experience change, and whether the Apple watch can detect these changes. Ultimately, this knowledge is being used to design proactive tools and signatures that can predict complications or symptom changes before they happen.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This trial is evaluating whether Apple Watch-based remote monitoring can help doctors track symptoms and health changes in people with glioblastoma — an aggressive brain tumor — during treatment or surveillance, allowing for earlier interventions. **You may be eligible if:** - You are 18 or older with newly diagnosed or recurrent glioblastoma - You are currently undergoing treatment or active monitoring for your brain tumor - You have a Karnofsky Performance Status of 70% or higher (meaning you can care for yourself and perform normal activities) - You can give informed consent - You or your caregiver has an Apple iPhone **You may NOT be eligible if:** - You are under 18 - You cannot give consent due to significant speech or language problems (aphasia) - You have tattoos or skin conditions on your wrist/forearm where the watch would be worn - You cannot tolerate wearing an Apple Watch for at least 12 hours a day on most days - You don't have access to an Apple iPhone Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEApple Watch

The wearable sensor device is the Apple Watch Series 6 or newer


Locations(1)

Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center

Cleveland, Ohio, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06129760


Related Trials